Experience with weekly doxorubicin (adriamycin) in hormone-refractory stage D2 prostate cancer

Christina Rangel, Haim Matzkin, Mark S. Soloway

Research output: Contribution to journalArticlepeer-review

35 Scopus citations

Fingerprint

Dive into the research topics of 'Experience with weekly doxorubicin (adriamycin) in hormone-refractory stage D2 prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences